1887

Abstract

Hepatitis C virus (HCV) replicon-harbouring cell lines possessing interferon (IFN)-resistant phenotypes have recently been established. These were divided into two classes: partially IFN resistant and highly IFN resistant. Here, the viral and cellular factors contributing to the IFN resistance of HCV replicon-harbouring cells were evaluated. The results revealed that cellular factors rather than viral factors contributed to a highly IFN-resistant phenotype. The possibility of genetic abnormality of the factors involved in IFN signalling was investigated. As a result, nonsense mutations and deletions in type I IFN receptor genes (IFNAR1 and IFNAR2c) were found in replicon-harbouring cells showing a highly IFN-resistant phenotype, but rarely appeared in cells showing a partially IFN-resistant phenotype. Furthermore, similar genetic alterations were also found in IFN-resistant phenotype, replicon-harbouring cell lines obtained additionally by IFN- treatment. Moreover, it was shown that ectopic expression of wild-type IFNAR1 in IFN-resistant phenotype, replicon-harbouring cells possessing the IFNAR1 mutant restored type I IFN signalling.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.81124-0
2005-10-01
2020-08-08
Loading full text...

Full text loading...

/deliver/fulltext/jgv/86/10/2787.html?itemId=/content/journal/jgv/10.1099/vir.0.81124-0&mimeType=html&fmt=ahah

References

  1. Akagi T., Shishido T., Murata K., Hanafusa H. 2000; v-Crk activates the phosphoinositide 3-kinase/AKT pathway in transformation. Proc Natl Acad Sci U S A 97:7290–7295 [CrossRef]
    [Google Scholar]
  2. Choo Q. L., Kuo G., Weiner A. J., Overby L. R., Bradley D. W., Houghton M. 1989; Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244:359–362 [CrossRef]
    [Google Scholar]
  3. Dansako H., Naganuma A., Nakamura T., Ikeda F., Nozaki A., Kato N. 2003; Differential activation of interferon-inducible genes by hepatitis C virus core protein mediated by the interferon stimulated response element. Virus Res 97:17–30 [CrossRef]
    [Google Scholar]
  4. Frese M., Pietschmann T., Moradpour D., Haller O., Bartenschlager R. 2001; Interferon- α inhibits hepatitis C virus subgenomic RNA replication by an MxA-independent pathway. J Gen Virol 82:723–733
    [Google Scholar]
  5. Frese M., Schwarzle V., Barth K., Krieger N., Lohmann V., Mihm S., Haller O., Bartenschlager R. 2002; Interferon- γ inhibits replication of subgenomic and genomic hepatitis C virus RNAs. Hepatology 35:694–703 [CrossRef]
    [Google Scholar]
  6. Hadziyannis S. J., Sette H. Jr, Morgan T. R. 11 other authors 2004; Peginterferon- α 2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose. Ann Intern Med 140:346–355 [CrossRef]
    [Google Scholar]
  7. Hijikata M., Mizushima H., Tanji Y., Komoda Y., Hirowatari Y., Akagi T., Kato N., Kimura K., Shimotohno K. 1993; Proteolytic processing and membrane association of putative nonstructural proteins of hepatitis C virus. Proc Natl Acad Sci U S A 90:10773–10777 [CrossRef]
    [Google Scholar]
  8. Ikeda M., Yi M., Li K., Lemon S. M. 2002; Selectable subgenomic and genome-length dicistronic RNAs derived from an infectious molecular clone of the HCV-N strain of hepatitis C virus replicate efficiently in cultured Huh7 cells. J Virol 76:2997–3006 [CrossRef]
    [Google Scholar]
  9. Ikeda M., Abe K., Dansako H., Nakamura T., Naka K., Kato N. 2005; Efficient replication of a full-length hepatitis C virus genome, strain O, in cell culture, and development of a luciferase reporter system. Biochem Biophys Res Commun 329:1350–1359 [CrossRef]
    [Google Scholar]
  10. Kato N. 2001; Molecular virology of hepatitis C virus. Acta Med Okayama 55:133–159
    [Google Scholar]
  11. Kato N., Hijikata M., Ootsuyama Y., Nakagawa M., Ohkoshi S., Sugimura T., Shimotohno K. 1990; Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis. Proc Natl Acad Sci U S A 87:9524–9528 [CrossRef]
    [Google Scholar]
  12. Kato N., Sugiyama K., Namba K., Dansako H., Nakamura T., Takami M., Naka K., Nozaki A., Shimotohno K. 2003; Establishment of a hepatitis C virus subgenomic replicon derived from human hepatocytes infected in vitro. Biochem Biophys Res Commun 306:756–766 [CrossRef]
    [Google Scholar]
  13. Kato N., Nakamura T., Dansako H., Namba K., Abe K., Nozaki A., Naka K., Ikeda M., Shimotohno K. 2005; Genetic variation and dynamics of hepatitis C virus replicons in long-term cell culture. J Gen Virol 86:645–656 [CrossRef]
    [Google Scholar]
  14. Kishine H., Sugiyama K., Hijikata M. 7 other authors 2002; Subgenomic replicon derived from a cell line infected with the hepatitis C virus. Biochem Biophys Res Commun 293:993–999 [CrossRef]
    [Google Scholar]
  15. Kuo G., Choo Q. L., Alter H. J. 17 other authors 1989; An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 244:362–364 [CrossRef]
    [Google Scholar]
  16. Lohmann V., Korner F., Koch J., Herian U., Theilmann L., Bartenschlager R. 1999; Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 285:110–113 [CrossRef]
    [Google Scholar]
  17. Machida K., Cheng K. T.-N., Sung V. M.-H., Lee K. J., Levine A. M., Lai M. M. 2004a; Hepatitis C virus infection activates the immunologic (type II) isoform of nitric oxide synthase and thereby enhances DNA damage and mutations of cellular genes. J Virol 78:8835–8843 [CrossRef]
    [Google Scholar]
  18. Machida K., Cheng K. T.-N., Sung V. M.-H., Shimodaira S., Lindsay K. L., Levine A. M., Lai M.-Y., Lai M. M. 2004b; Hepatitis C virus induces a mutator phenotype: enhanced mutations of immunoglobulin and protooncogenes. Proc Natl Acad Sci U S A 101:4262–4267 [CrossRef]
    [Google Scholar]
  19. Naganuma A., Nozaki A., Tanaka T., Sugiyama K., Takagi H., Mori M., Shimotohno K., Kato N. 2000; Activation of the interferon-inducible 2′-5′-oligoadenylate synthetase gene by hepatitis C virus core protein. J Virol 74:8744–8750 [CrossRef]
    [Google Scholar]
  20. Naganuma A., Dansako H., Nakamura T., Nozaki A., Kato N. 2004; Promotion of microsatellite instability by hepatitis C virus core protein in human non-neoplastic hepatocyte cells. Cancer Res 64:1307–1314 [CrossRef]
    [Google Scholar]
  21. Naka K., Ikeda M., Abe K., Dansako H., Kato N. 2005; Mizoribine inhibits hepatitis C virus RNA replication: effect of combination with interferon- α . Biochem Biophys Res Commun 330:871–879 [CrossRef]
    [Google Scholar]
  22. Namba K., Naka K., Dansako H., Nozaki A., Ikeda M., Shiratori Y., Shimotohno K., Kato N. 2004; Establishment of hepatitis C virus replicon cell lines possessing interferon-resistant phenotype. Biochem Biophys Res Commun 323:299–309 [CrossRef]
    [Google Scholar]
  23. Nozaki A., Ikeda M., Naganuma A., Nakamura T., Inudoh M., Tanaka K., Kato N. 2003; Identification of a lactoferrin-derived peptide possessing binding activity to hepatitis C virus E2 envelope protein. J Biol Chem 278:10162–10173 [CrossRef]
    [Google Scholar]
  24. Pawlotsky J. M. 2000; Hepatitis C virus resistance to antiviral therapy. Hepatology 32:889–896 [CrossRef]
    [Google Scholar]
  25. Pfeffer L. M., Mullersman J. E., Pfeffer S. R., Murti A., Shi W., Yang C. H. 1997; STAT3 as an adapter to couple phosphatidylinositol 3-kinase to the IFNAR1 chain of the type I interferon receptor. Science 276:1418–1420 [CrossRef]
    [Google Scholar]
  26. Saito I., Miyamura T., Ohbayashi A. 10 other authors 1990; Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc Natl Acad Sci U S A 87:6547–6549 [CrossRef]
    [Google Scholar]
  27. Thomas D. L. 2000; Hepatitis C epidemiology. Curr Top Microbiol Immunol 242:25–41
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.81124-0
Loading
/content/journal/jgv/10.1099/vir.0.81124-0
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error